After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...

City of Hope has launched a national clinical trial network designed to improve cancer care and reach medically-underserved ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...

MetaVia will now be investigating the candidate at two different titration levels in 16-week trials for obesity.

A UC San Diego lab recently announced a pair of scientific breakthroughs for Pitt-Hopkins and Rett syndromes that are slated ...

To be accepted into a clinical trial, all potential participants must meet the "eligibility criteria" by having similar ...

A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic makeup, with an increasing trend of trials underrepresenting Black and ...

Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

A stylized image of Max Barnhart sitting on a chair with his arm on a pillow, receiving an IV infusion. The background is a grid containing a microscope image of malaria parasites flanked on each side ...